Annual Revenue
$1.96 B
+$611.88 M+45.26%
31 December 2023
Summary:
Evolent Health annual revenue is currently $1.96 billion, with the most recent change of +$611.88 million (+45.26%) on 31 December 2023. During the last 3 years, it has risen by +$1.06 billion (+116.30%). EVH annual revenue is now at all-time high.EVH Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$621.40 M
-$25.74 M-3.98%
30 September 2024
Summary:
Evolent Health quarterly revenue is currently $621.40 million, with the most recent change of -$25.74 million (-3.98%) on 30 September 2024. Over the past year, it has increased by +$65.35 million (+11.75%). EVH quarterly revenue is now -3.98% below its all-time high of $647.14 million, reached on 30 June 2024.EVH Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$2.46 B
+$110.39 M+4.69%
30 September 2024
Summary:
Evolent Health TTM revenue is currently $2.46 billion, with the most recent change of +$110.39 million (+4.69%) on 30 September 2024. Over the past year, it has increased by +$500.36 million (+25.48%). EVH TTM revenue is now at all-time high.EVH TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVH Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +11.8% | +25.5% |
| 3 y3 years | +116.3% | +150.2% | +171.4% |
| 5 y5 years | +185.8% | +704.3% | +258.6% |
EVH Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +116.3% | -4.0% | +150.2% | at high | +171.4% |
| 5 y | 5 years | at high | +185.8% | -4.0% | +704.3% | at high | +258.6% |
| alltime | all time | at high | +7550.3% | -4.0% | +5867.0% | at high | >+9999.0% |
Evolent Health Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $621.40 M(-4.0%) | $2.46 B(+4.7%) |
| June 2024 | - | $647.14 M(+1.2%) | $2.35 B(+8.2%) |
| Mar 2024 | - | $639.65 M(+15.0%) | $2.18 B(+10.8%) |
| Dec 2023 | $1.96 B(+45.3%) | $556.05 M(+8.8%) | $1.96 B(+9.7%) |
| Sept 2023 | - | $511.01 M(+8.9%) | $1.79 B(+9.7%) |
| June 2023 | - | $469.14 M(+9.7%) | $1.63 B(+10.1%) |
| Mar 2023 | - | $427.69 M(+11.8%) | $1.48 B(+9.7%) |
| Dec 2022 | $1.35 B(+48.9%) | $382.43 M(+8.5%) | $1.35 B(+11.0%) |
| Sept 2022 | - | $352.58 M(+10.2%) | $1.22 B(+12.0%) |
| June 2022 | - | $319.94 M(+7.7%) | $1.09 B(+9.9%) |
| Mar 2022 | - | $297.06 M(+19.6%) | $989.94 M(+9.0%) |
| Dec 2021 | $907.96 M(-1.8%) | $248.36 M(+11.6%) | $907.96 M(+0.2%) |
| Sept 2021 | - | $222.47 M(+0.2%) | $906.13 M(-1.9%) |
| June 2021 | - | $222.06 M(+3.2%) | $923.24 M(+0.5%) |
| Mar 2021 | - | $215.07 M(-12.8%) | $918.48 M(-0.7%) |
| Dec 2020 | $924.64 M(+34.6%) | $246.54 M(+2.9%) | $924.64 M(+22.4%) |
| Sept 2020 | - | $239.57 M(+10.2%) | $755.37 M(+2.6%) |
| June 2020 | - | $217.30 M(-1.8%) | $735.94 M(+3.6%) |
| Mar 2020 | - | $221.23 M(+186.3%) | $710.60 M(+3.4%) |
| Dec 2019 | $687.12 M | $77.26 M(-64.9%) | $687.12 M(-14.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $220.14 M(+14.7%) | $802.96 M(+9.6%) |
| June 2019 | - | $191.96 M(-2.9%) | $732.77 M(+7.0%) |
| Mar 2019 | - | $197.76 M(+2.4%) | $685.11 M(+9.3%) |
| Dec 2018 | $627.06 M(+44.2%) | $193.10 M(+28.8%) | $627.06 M(+14.5%) |
| Sept 2018 | - | $149.95 M(+3.9%) | $547.69 M(+8.3%) |
| June 2018 | - | $144.30 M(+3.3%) | $505.65 M(+7.9%) |
| Mar 2018 | - | $139.71 M(+22.8%) | $468.43 M(+7.7%) |
| Dec 2017 | $434.95 M(+71.1%) | $113.73 M(+5.4%) | $434.95 M(+6.3%) |
| Sept 2017 | - | $107.91 M(+0.8%) | $409.23 M(+13.2%) |
| June 2017 | - | $107.07 M(+0.8%) | $361.53 M(+16.3%) |
| Mar 2017 | - | $106.24 M(+20.7%) | $310.98 M(+22.3%) |
| Dec 2016 | $254.19 M(+162.4%) | $88.01 M(+46.2%) | $254.19 M(+19.8%) |
| Sept 2016 | - | $60.21 M(+6.5%) | $212.24 M(+10.3%) |
| June 2016 | - | $56.52 M(+14.3%) | $192.43 M(+31.5%) |
| Mar 2016 | - | $49.45 M(+7.4%) | $146.33 M(+51.0%) |
| Dec 2015 | $96.88 M(+277.4%) | $46.06 M(+14.0%) | $96.88 M(+90.6%) |
| Sept 2015 | - | $40.41 M(+288.0%) | $50.82 M(+388.0%) |
| June 2015 | - | $10.41 M(-48.1%) | $10.41 M(-48.1%) |
| Mar 2014 | - | $20.08 M | $20.08 M |
| Dec 2013 | $25.67 M | - | - |
FAQ
- What is Evolent Health annual revenue?
- What is the all time high annual revenue for Evolent Health?
- What is Evolent Health quarterly revenue?
- What is the all time high quarterly revenue for Evolent Health?
- What is Evolent Health quarterly revenue year-on-year change?
- What is Evolent Health TTM revenue?
- What is the all time high TTM revenue for Evolent Health?
- What is Evolent Health TTM revenue year-on-year change?
What is Evolent Health annual revenue?
The current annual revenue of EVH is $1.96 B
What is the all time high annual revenue for Evolent Health?
Evolent Health all-time high annual revenue is $1.96 B
What is Evolent Health quarterly revenue?
The current quarterly revenue of EVH is $621.40 M
What is the all time high quarterly revenue for Evolent Health?
Evolent Health all-time high quarterly revenue is $647.14 M
What is Evolent Health quarterly revenue year-on-year change?
Over the past year, EVH quarterly revenue has changed by +$65.35 M (+11.75%)
What is Evolent Health TTM revenue?
The current TTM revenue of EVH is $2.46 B
What is the all time high TTM revenue for Evolent Health?
Evolent Health all-time high TTM revenue is $2.46 B
What is Evolent Health TTM revenue year-on-year change?
Over the past year, EVH TTM revenue has changed by +$500.36 M (+25.48%)